[Blackfan-Diamond disease and malignancy: cause effect relationships?]. 1992

D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
Service de chimiothérapie massive et transplantation médullaire, hôpital Nord, Saint-Priest-en-Jarez, France.

The authors report on a 24-year old patient with Blackfan-Diamond syndrome who developed a Hodgkin's disease. This patient became transfusion-dependent at the age of 10, after an initial period of corticosensitivity, and after failure of androgens. He developed hemochromatosis despite from parenteral chelation therapy. He died of infectious complications 4 months after the diagnosis of Hodgkin's lymphoma. A review of the literature shows an increased incidence of malignancies in Blackfan-Diamond syndrome (three cases of leukemia), and in similar disease (thalassemia and sickle cell disease), but not in other patients with hemosiderosis (primitive hemochromatosis, end-stage renal failure under dialysis). Etiopathogenic hypotheses are discussed.

UI MeSH Term Description Entries
D008297 Male Males
D005199 Fanconi Anemia Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id Anemia, Fanconi,Fanconi Hypoplastic Anemia,Fanconi Pancytopenia,Fanconi Panmyelopathy,Fanconi's Anemia,Anemia, Fanconi's,Anemias, Fanconi,Fanconi Anemias
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
January 1993, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
January 1988, The American journal of pediatric hematology/oncology,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
December 1997, Hematology/oncology clinics of North America,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
January 1962, Nouvelle revue francaise d'hematologie,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
March 2000, Current opinion in hematology,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
November 1993, The Veterinary record,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
September 2000, Bailliere's best practice & research. Clinical haematology,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
January 2011, Hematology. American Society of Hematology. Education Program,
D Frappaz, and O Richard, and S Perrot, and V Gautheron, and J C Elian, and F Freycon
December 2021, Hematology. American Society of Hematology. Education Program,
Copied contents to your clipboard!